PACB
$1.38
Revenue | $58.36Mn |
Net Profits | $-82.02Mn |
Net Profit Margins | -140.55% |
Pacific Biosciences Of California, Inc.’s revenue jumped 113.35% since last year same period to $58.36Mn in the Q4 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated 4.79% jump in its revenue since last 3-months.
Pacific Biosciences Of California, Inc.’s net profit fell -2.73% since last year same period to $-82.02Mn in the Q4 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated -22.65% fall in its net profits since last 3-months.
Pacific Biosciences Of California, Inc.’s net profit margin jumped 51.85% since last year same period to -140.55% in the Q4 2023. On a quarterly growth basis, Pacific Biosciences Of California, Inc. has generated -17.05% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.27 |
EPS Estimate Current Year | -0.27 |
Pacific Biosciences Of California, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.27 - a 6.9% jump from last quarter’s estimates.
Pacific Biosciences Of California, Inc.’s earning per share (EPS) estimates for the current year stand at -0.27.
Earning Per Share (EPS) | -0.31 |
Pacific Biosciences Of California, Inc.’s earning per share (EPS) jumped 16.22% since last year same period to -0.31 in the Q4 2023. This indicates that the Pacific Biosciences Of California, Inc. has generated 16.22% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-03 | -0.33 | -0.26 | 21.21% |
2023-05-04 | -0.33 | -0.36 | -9.09% |
2023-08-04 | -0.32 | -0.28 | 12.5% |
2023-12-31 | -0.29 | -0.31 | -6.9% |